Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.485
+0.135 (5.74%)
Jan 2, 2026, 3:57 PM EST - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $370.27 million as of January 2, 2026. Its market cap has increased by 12,409.40% in one year.
Market Cap
370.27M
Enterprise Value
365.26M
1-Year Change
12,409.40%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $370.27M, an increase of 393.25%. That is a compound annual growth rate of 40.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |